CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.
Cancers (Basel)
; 14(9)2022 Apr 26.
Article
in En
| MEDLINE
| ID: mdl-35565280
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2022
Document type:
Article
Affiliation country:
España